You decide… Accidental death OR SUICIDE ?

death in this case was a combined overdose of methadone and (alcohol)

http://www.grandforksherald.com/news/region/4082563-overdose-death-leads-reprimand-minnesota-physician

Overdose death leads to reprimand for Minnesota physician

The 2014 overdose death of a patient has led to a local physician being fined and reprimanded by the Minnesota Board of Medical Practice.

Dr. Timothy L. Burke, an infectious-disease specialist for Essentia Health-Duluth Clinic at the time of the incident, was cited for “unethical and unprofessional conduct,” said a news release from the state board earlier this month.

Burke’s medical license, issued by the board in 1995, has been placed on conditional status and he must complete a series of steps for it to be restored. He was also fined a civil penalty of $2,500.

Neither Burke nor his attorney, Steven Schwegman of St. Cloud, could be reached for comment.

A July 2015 internal publication for Essentia Health, Daily Dose, featured a story announcing Burke’s retirement. While retired from practice with Essentia Health, he “still works occasionally as a casual physician,” said Essentia spokeswoman Maureen Talarico in an email. She declined elaboration by adding, “Matters between the Minnesota Board of Medical Practice and the physicians it licenses are separate from the physicians’ relationships with Essentia Health.”

Executive Director Ruth Martinez told the News Tribune the state board has the authority to reprimand its licensed physicians, suspend licenses, invite someone to voluntarily surrender a license and even revoke licenses. The reprimand is a part of a physician’s record forever, she said.

According to a stipulation agreed upon by the board and Burke, filed by the state board, Burke had treated the male patient since 2006, authorizing controlled substances for the patient, including concurrent prescriptions for methadone and clonazepam, “based on the patient’s claims of pain or other symptoms.” The stipulation listed the patient with multiple health issues, including “chemical dependency, polysubstance abuse, mental health issues and personality disorder.”

Burke, the stipulation said, failed the patient in numerous ways related to the medications, including failing “to conduct routine biological fluid screens to monitor” the patient’s compliance with his medication regimen or use of additional drugs and alcohol.

The patient had been living in a group home and when he decided to leave the group home, Burke “explained to the patient that he had a number of reservations” about the patient’s decision based on the his history of alcohol misuse and medication noncompliance.

Upon the patient’s release from the group home, Burke performed an exam and requested the group home release medications to the patient.

The patient was “later found dead,” the stipulation said. An autopsy by a medical examiner determined ” ‘death in this case was accidental and secondary to a combined overdose of methadone and (alcohol).’ ” Chronic obstructive pulmonary disease was also listed as a contributing factor in the man’s death, the stipulation said.

The state board first received a complaint about Burke’s treatment of the patient in August 2014, the stipulation said. The stipulation does not indicate who filed the complaint.

In addition to failing to perform body fluid screenings for medication levels, the stipulation said Burke failed to “document objective clinical findings to support the need for initiating or renewing the medications, failed to explore non-narcotic treatment options, failed to document an overall treatment plan, and failed to provide referrals or establish care,” for the patient with a primary care physician, a psychiatrist or other specialists to coordinate the patient’s overall health care.

While he was in the group home, “the group home maintained control” of the patient’s medications to ensure proper administration, the stipulation said. Burke then “failed to monitor the efficacy of the medications” and “failed to implement a controlled substance contract,” the stipulation said.

In December 2015, Burke appeared before the state board and acknowledged he prescribed the narcotics for the patient, who “had a history of chronic pain, depression, anxiety and alcohol use,” the stipulation said.

In order to petition for the reinstatement of his license unconditionally, Burke is required to read policy for pain control and a clinical guide for responsible opioid prescribing, as well as complete courses on chemical dependency awareness and chronic pain management.

Upon completion of the readings and coursework, he will need to write a paper describing what he learned, how he might treat the patient of the investigation differently, and how he will implement that knowledge into his practice.

Burke is listed in the stipulation as having been born in 1953, with a birthday this month, putting his age at 62 or 63.

According to the story of Burke’s retirement published in the Essentia’s Daily Dose, Burke “was the physician epidemiologist at St. Mary’s Medical Center from 2000 to 2013. He served as chief of the Department of Medicine from 2005 to 2010 and was the chief of Medical Staff from 2011 to 2014.”

Burke wrote columns for the News Tribune during the H1N1 flu crisis in 2012-13 and was often cited as a source for News Tribune stories during flu season. In the Daily Dose publication announcing his retirement, Dr. Rajesh Prabhu described Burke as ” ‘an excellent clinician and universally well respected colleague.’ “

New Data: Illegally obtained opioids is the “driving force” behind epidemic

But just 8.3 percent of those decedents had an active opioid prescription in the same month as their death, DPH said, and in 83 percent of opioid overdose deaths that had a toxicology report completed the person who died had “illegally-obtained or likely illegally-obtained substances” in their system at their time of death.

BOSTON (STATE HOUSE NEWS SERVICE) – Authorized by a law signed last year to collect information from health care agencies, law enforcement departments, the court system and other state agencies, the Department of Public Health is working to demystify the data and identify previously unseen trends in the state’s opioid crisis.

In a preliminary report filed with the Legislature this month, DPH Commissioner Monica Bharel wrote that other states have already called Massachusetts to learn more about its approach to using data analytics to inform the state’s response to the scourge of opioid misuse and overdose.

“The ability to look as broadly and as deeply at public health data has been a unique challenge, but one that has given us a much greater understanding of the current opioid epidemic,” Bharel wrote. The approach “has enabled Massachusetts to serve as a national example for the possibilities of public health’s ability to leverage data warehousing to respond to pressing policy and health concerns by allowing existing data to be used in new and innovative ways to support policy and decision making.”

Working with the Center for Health Information and Analysis, MassIT, the Office of the Chief Medical Examiner, MassHealth, the Department of Correction and others, DPH has developed a model that allows for “simultaneous analysis of 10 data sets with information relevant to opioid deaths.”

The collaborative effort to link data sets has allowed DPH to dig into questions like, “Does an abnormally high number of prescribing physicians increase a patient’s risk of fatal overdose?”

The preliminary answer, DPH reported, is yes. The agency reported that the risk of a fatal opioid overdoses is seven times greater for individuals who use three or more prescribers within three months. DPH also reported that the concurrent use of opioids and benzodiazepines is associated with a four-fold increase in risk of a fatal opioid overdose.

The data analytics approach was also used to better understand the link between opioid overdose deaths and the legal use of prescribed opioids. DPH reported that “at least” two out of every three people who died of an opioid overdose had been prescribed an opioid between 2011 and 2014.

But just 8.3 percent of those decedents had an active opioid prescription in the same month as their death, DPH said, and in 83 percent of opioid overdose deaths that had a toxicology report completed the person who died had “illegally-obtained or likely illegally-obtained substances” in their system at their time of death.

In its report, DPH points to the information on illegally-obtained substances as “evidence to support an emerging hypothesis that illegally-obtained substances are the driving force behind” the state’s epidemic.

Since 2000, Massachusetts has seen a 350 percent increase in opioid-related deaths — from 338 in 2000 to an estimated 1,526 in 2015 — including record-setting numbers of deaths in each of the last four years, according to DPH.

 

Robbing pharmacies is KIDS PLAY ?

1-foam-finger

Indiana leads U.S. again in pharmacy robberies

Despite some targeted measures to protect pharmacies, Indiana isn’t shedding its unwanted designation as the No. 1 state for pharmacy robberies.

Consider this statistic: Indiana had more pharmacy robberies from the beginning of 2013 to May of this year than any other state.

Indiana logged 367 robberies, while California — with a population about six times larger — came in second with 310 robberies in the same time period. In 2015, 175 robberies occurred, 132 in Marion County alone, more than the entire state of California for the previous year, said Donna Wall, president of the Indiana Board of Pharmacy.

On Tuesday, the members of the Governor’s Task Force on Drug Enforcement, Treatment, and Prevention mulled these troubling statistics and more as they heard from Wall and others fighting on the front lines to improve the situation.

Randy Hitchens, executive vice president of the Indiana Pharmacists Alliance, said he frequently fields calls from concerned pharmacists. Hitchens has little solace to offer.

“We feel a little weak,” Hitchens said. “We scratch our heads about what we can do.”

Nor is it just traditional robberies in pharmacies. Every time the pharmacy board meets, members have to revoke the license of one or two pharmacy techs because they were diverting pills, Wall said.

But the bulk of the threat does not come from the inside.

Last year, 17 Marion County pharmacies were robbed three times, three pharmacies were robbed four times, and four pharmacies were robbed five times.

“Last year was just a horrible, horrible year,” Indianapolis Metropolitan Police Department Lt. Craig McCart told the drug task force.

Many stores — especially those in Marion County — have taken steps to improve security, adding armed guards and time release safes to house the most desired medications, mostly opioids such as oxycodone.

Still, there have been 64 pharmacy robberies since the start of the year in Indiana. IMPD considers the fact that it has seen “only” 43 pharmacy robberies since January a relative success.

“It’s still a huge problem, but we really are looking at it as a bit of a victory because we are so far below where we were last year,” McCart said.

“As security measures in Marion County are ramping up, they’re going out to other places,” Wall said.

Whenever police in Louisville, Ky., Cincinnati, Kokomo, Danville or Muncie identify a pharmacy robbery suspect in their jurisdictions, the person almost always hails from Indianapolis, McCart said.

The people behind the robberies have a well-developed system, he said. Rarely do they use what they steal. Often they enlist juveniles, many with no criminal record, offering them $1,000 to $2,000 per job. The juveniles don’t stand to do much jail time even if they get caught.

In some cases, the juveniles take the pills and run out to an older guy, waiting in a car in a parking lot, McCart said. The criminals have become so savvy that in many instances, they have the juvenile give them the stolen pills but keep the bottles in case they are equipped with GPS trackers.

“They’re fairly sophisticated,” McCart said. “Right now, we’re having some degree of success. But it’s still obviously a huge problem.”

The problem has extended to pharmacies statewide, Wall said. Of the seven people on the pharmacy board, one pharmacist, who has his own store, has had a break-in in the past month. Another, who works in a chain, has had two attempted robberies in the past four months.

“This is the type of problem we’re dealing with, and this is why the pharmacy board is really anxious, and anyone in pharmacy is really anxious, about what’s going on here,” Wall said. “So far, we have been really blessed that no one has been injured. … But it’s really scary.”

Call IndyStar reporter Shari Rudavsky at (317) 444-6354. Follow her on Twitter: @srudavsky.

They are suppose to save you money…. BUT ARE THEY ?

Uncovering the group driving up the cost of medication

http://www.10tv.com/article/uncovering-group-driving-cost-medication#

To make sure you are not getting the “short end of the stick”… www.goodrx.com will give you retail prices that you should pay. If your copay – determined by your insurance company… is more than that price… you know that your insurance company is more concerned about their profits than yours costs… Ask the Pharmacist to reverse the claim and either charge you  the www.goodrx.com  price or their normal cash price. Every company has the right to try and make a profit.. but.. not at the expense of overcharging the uninformed or naive.

Published: .
Updated: .

When you go to the pharmacy, chances are you expect you are getting a fair price for your medication, especially if insurance is involved. But some local pharmacists want you to know that may not always be the case. They said they are part of an equation that can include some dishonest middlemen, not always, but some of the time.

The traditionally insured prescription world relies on something called the pharmacy benefit manager or PBM.

“A pharmacy benefit manager is the middleman between the insurance company and the pharmacy,” Antonio Ciaccia from the Ohio Pharmacists Association said.

According to Ciaccia, the three biggest middlemen in the business, Express Scripts, CVS Caremark and Optum Rx, represent more than 70 percent of the patients in the U.S. marketplace.

“They are able to use those patient lives to their advantage to negotiate better pricing on drugs or lower reimbursements to pharmacies because of the bodies they represent,” Ciaccia said.

But some pharmacy owners say not all patients are seeing that better pricing. They did not want to share their names because they say they signed contracts to work with the PBMs’ patients and those contracts have rules.

“Part of the provisions in those contracts…explicitly prohibit a pharmacist from saying anything that would be derogatory or negative against the PBM,” Ciaccia explains. That includes letting a customer know when he or she might be paying perhaps more than they should.

He calls money the PBM makes by overcharging the patient a ‘clawback.’

“This isn’t the rule of thumb, but we’re seeing it more and more where the patient is charged a higher co-pay than the cost of the drug would be without insurance,” he said.

One central Ohio pharmacy owner shared PBM paperwork with 10TV, including a transaction for an osteoporosis drug. He said when his employee sent the claim to the PBM via computer, it sent back figures compiled from its non-disclosed databank.

The PBM printout directed the pharmacist to charge the customer a co-pay of $189, way more than the $116 the PBM set for the cost of the drug and to fill the prescription. And way more than the $70 the pharmacy actually paid to acquire the pills.

The pharmacy made a $45 profit, but $73 went back to or stayed with the PBM. It was one case in five pages, most of which were in the $1 to $10 range.

In a recent survey by the National Community Pharmacists Association, 83 percent of 640 independent pharmacists across the country reported seeing at least 10 co-pay clawbacks in the past month.

One local pharmacist called it ‘gouging’ and said some PBMs take advantage of a contract-controlled system that prohibits pharmacists from sharing information with customers. When one of his employees did, “That patient went back to the employer, the employer complained to the PBM, the PBM called us and said if you continue to provide pricing information, we are going to cancel your contract.”

And if the pharmacy lost the contract, it would also lose customers. So silence becomes golden, but some patients question the pharmacist.

“And we try to explain, ‘we’re just the messenger,’,” another local pharmacist said. “We don’t decide these prices.”

Local pharmacists said they don’t exactly know where the money that goes back to the PBM ends up because it’s not clear.

10TV contacted the PBM connected to the prescription example from this story. Because the issue involved a co-pay which is insurance-plan based, Optum Rx pointed us to sister company United Healthcare for plan perspective. It said, “We have reviewed our pharmacy benefits and will update our plans to ensure UHC members pay the lowest price at the pharmacy.”

But critics say when PBMs place drugs in price tiers, they have a hand in the co-pay, too.

Ciaccia says “there is no transparency” and it is so convoluted, it makes it hard for any customer to know what questions to ask.

Industry experts say here are two: How much does the prescription cost?

It might be information the pharmacist can’t offer up, but will sometimes be able to answer if asked.

The other: Where can you go to find drug pricing information so you know if your co-pay is more?

Experts point to NADAC figures on Medicaid.gov that detail the National Average Drug Acquisition costs for a long list of drugs.

Optum Rx would not comment on what pharmacists called the patient overcharge described in this story without being able to see the full transaction. We sent numbers from our story and Optum said that was not enough to draw conclusions.

As for the two other big PBMs, Express Scripts said the co-pay is set by the employer. CVS Caremark said, “If the pharmacy’s cash price is lower than the co-pay, the patient would be charged the lower price.”

Meanwhile, the Pharmaceutical Care Management Association said “patients should not have to pay more than a network drugstore’s submitted charges to the health plan. Nationwide, PBMs are working to reduce the cost of prescription drugs.

In Ohio, PBMs are projected to save the state’s employers, unions, government programs, and consumers $24.7 billion on drug benefit costs over the next decade.”

Independent Pharmacies – where your trust is more important than your money

U.S. Senator Passes Bill to Increase Medical Marijuana Research

U.S. Senator Passes Bill to Increase Medical Marijuana Research

http://blogs.christianpost.com/news-section/u-s-senator-passes-bill-to-increase-medical-marijuana-research-27920/

In Salt Lake City, Senator Orrin Hatch has recently unveiled a bipartisan bill which will allow researchers to perform further study on the potential medical benefits of marijuana. Hatch introduced this regulation along with other senators from Delaware, Hawaii and North Carolina, making a statement in which he said that policymakers are in need of further scientific evidence before they can make better informed decisions about the legalisation of the drug for medical use. He said that in his home state of Utah, debates earlier in the year regarding whether or not to expand marijuana legalisation to medical purposes made clear the need for more and improved scientific research.


Medical Benefits of Marijuana

Marijuana, along with its dozens of active components, has shown some substantial promise for treating a range of different illnesses. However, currently classed as a Schedule I substance, the drug is considered to have no medical benefits or use, and a high potential for abuse. It shares this classification with drugs such as heroin or cocaine, and is currently illegal to study without first going through a range of significant bureaucratic hurdles. Paediatrics chairman at the University of Utah, Dr. Ed Clark, said that he has not yet seen the bill but is in full support of any efforts to open up research on medical cannabis, including studies on the different properties of CBD oil.

Current Research
Although research on marijuana is not yet legal, it is possible to research some of the different compounds of the drug as standalone substances. For example, the University of Utah is currently carrying out research on a cannabidiol product known as Epidiolex and the effects it has on children with epilepsy. Cannabidiol is derived from the marijuana plant put does not contain the substance THC, which causes the ‘high’ of marijuana. In 2013, a law passed in Utah known as ‘Charlie’s Law’ allowed hemp oil to be used to treat people suffering from intractable epilepsy, however, marijuana itself still remains illegal under federal law. Clark believes that marijuana should be controlled, but in a manner which is consistent with the known risks of the drug and based on scientific evidence.

What the Bill Means
The new bill would stop short of requesting that the DEA downgrade marijuana from a Schedule I substance to Schedule II. In a statement, Senator Hatch’s communications director J.P. Freire said that the purpose of the bill is to facilitate research in order to ensure that lawmakers are more informed about whether or not marijuana should be moved from Schedule I to a lower schedule. The bill will also direct the DEA to allow more marijuana growers. As of now, the DEA has issued just once license, which is held by the University of Mississippi, for the growth and cultivation of marijuana for research purposes.

In order to provide lawmakers with more information and research surrounding the medical benefits of marijuana, the bill aims to streamline the DEA approval process and eliminate stringent stipulations regarding the drug set by the DEA.

The WORD “PAIN” not mentioned once in 55 pages

Here is the 2016 DEMOCRATIC PLATFORM  using the Adobe word search function and not one mention of the word PAIN in the 55 pages of this document… there are several mention of the word ADDICTION in their platform.  There is also several mentions of the word DISABILITY..

You can come to your own conclusion as to where disabled chronic pain pt’s future stands !

 

Democratic-Party-Platform-7.21.16-no-lines

A refresher course in CIVICS

It was so many years ago that I sat thru Civics Class…  I took the class in summer school at the local public high school. My parents sent me to 12 yrs of parochial school and because there was a religion class every day.. if I did not go to summer school.. I would not have a study hall .. because I was on the academic path to go to college. I went to the local high school several summers in a row and found the local high school much easier than my parochial school.  It was the summer before my SENIOR YEAR in high school.. I had just got my first car a few months before and it was SUMMER..  My focus on the details of Civics class was more about getting a passing grade than really what was going on about/within our government.. I had just turned 17…  it was SUMMER and come Sept .. I was going to be a SENIOR… Of course, back then… the government – both local,state, Federal.. was much less intrusive in our lives… The state I lived in had just imposed a TWO percent sales tax – today it is SEVEN PERCENT.

Over the last several years, I kept wondering why many “big wigs” in particularly Washington… would  seemingly break laws …”spit” in Congress’ face and walk away without any consequences… names like the head of IRS Lois Lerner, Attorney General Eric Holder and most recently Hillary Clinton.

Congress just seem to be impotent.. how can one of three branches of our government have no authority, they have hearings … AG Holder left office being held in contempt of Congress.

I struggle to understand why discrimination against chronic pain pts by those in healthcare goes unchallenged as violation of the ADA. It is well documented that the war on pts/doc was dramatically ramp up started during the 2009-2011 period and I wonder why.

So I started a little research on the three branches of our government… and found the following… the most interesting is A crucial function of the executive branch is to ensure that laws are carried out.  So it would seem that our President is at the top of the heap of ensuring that laws are enforced.I have made two other posts today that pointed out that both the FDA and OCR are failing their mission statements and we know that the DEA is failing their mission statement.  Congress passes our annual budget and while the House has passed a annual budget the Senate has failed to do so for 6-7 yrs in a row. IMO.. this election could be a watershed moment in our 240 yr history… leaving “the establishment” in charge of Congress and putting in a new President that is part of “the establishment”… will just be more of the same.  All you have to do is ask yourself… AM I BETTER OFF TODAY THAN I WAS EIGHT YEARS AGO  and do I want to better off in another four years ?

The Executive Branch

The executive branch consists of the president, vice president and 15 Cabinet-level departments such as State, Defense, Interior, Transportation and Education. The primary power of the executive branch rests with the president, who chooses his vice president, and his Cabinet members who head the respective departments. A crucial function of the executive branch is to ensure that laws are carried out and enforced to facilitate such day-to-day responsibilities of the federal government as collecting taxes, safeguarding the homeland and representing the United States’ political and economic interests around the world.

The Legislative Branch

The legislative branch consists of the Senate and the House of Representatives, collectively known as the Congress. The legislative branch, as a whole, is charged with passing the nation’s laws and allocating funds for the running of the federal government and providing assistance to the 50 U.S. states.

The Judicial Branch

The judicial branch consists of the United States Supreme Court and lower federal courts. The Supreme Court’s primary function is to hear cases that challenge the constitutionality of legislation or require interpretation of that legislation. The U.S. Supreme Court has nine Justices, who are chosen by the President, confirmed by the Senate. Once appointed, Supreme Court justices serve until they retire, resign, die or are impeached. 

The lower federal courts also decide cases dealing with the constitutionality of laws, as well as cases involving the laws and treaties of the U.S. ambassadors and public ministers, disputes between two or more states, admiralty law, also known as maritime law, and bankruptcy cases. Decisions of the lower federal courts can be and often are appealed to the U.S. Supreme Court.

Ontario to stop paying for higher-strength opioid painkillers

FentanylOntario to stop paying for higher-strength opioid painkillers

http://www.cbc.ca/beta/news/health/opioids-ontaio-delisting-1.3693862

Ontario will stop paying for higher-strength opioid medications through its Ontario Drug Benefit (ODB) program next January as part of its strategy to address the growing problem of addiction to the painkillers.

Opioids such as fentanyl and morphine are often prescribed to patients with chronic pain, but can often lead to addiction and overdose deaths.

To help fight what it calls the “growing problem of opioid addiction in Ontario,” the province’s Ministry of Health and Long-Term Care announced last week that it would stop paying for the following higher-strength long-acting opioids from its ODB drug formulary as of January 2017:

  • Morphine, 200 mg tablets.
  • Hydromorphone, 24 mg and 30 mg capsules.
  • Fentanyl, 75 mcg/hr and 100 mcg/hr patches.

The province will also delist 50 mg tablets of Meperidine, also known as Demerol. 

The ministry said it was giving six months notice of the funding changes to give patients time to consult with their doctors about changes that may be required to their drug treatment plan.

“Physicians should initiate this discussion as soon as possible with any patients affected by these changes,” the ministry advises in a notice on its website. 

Ontario’s drug benefit plan pays the cost of many prescription drugs for those 65 and over as well as for those on assistance. 

Lower doses better for patients

The Ontario government’s action followed its establishment of a “pain subcommittee” to carry out a review of narcotics prescribed for pain management. 

“The subcommittee indicated that lower opioid doses may improve patient outcomes,” the ministry said in a statement. “Since many patients on high doses may be considered ‘opioid failures,’ tapering or withdrawing opioid treatment may result in improved mood, pain and function, with less sedation, fatigue, constipation, etc.”

Deaths linked to opioid use in Canada have soared in recent years. 

A 2014 study found that opioids were related to one in eight deaths among young people in Ontario.

Rates of opioid-related death in the province increased by 242 per cent between 1991 and 2010, rising from 12.2 deaths per million in 1991 (127 deaths annually) to 41.6 deaths per million in 2010 (550 deaths annually). 

More recently, British Columbia declared a public health emergency in April after a dramatic increase in the number of overdose deaths from opioids like fentanyl.

Of the 201 overdose deaths recorded in B.C. in the first three months of 2016, 64 involved fentanyl, according to the province’s medical officer of health. 

 

So they changed the nomenclature… what is the end game here ?

NO MORE ADDICTS OR JUNKIES… JUST THOSE WHO USES OPIATES  – FOR ANY REASON ?

v\:* {behavior:url(#default#VML);} o\:* {behavior:url(#default#VML);} w\:* {behavior:url(#default#VML);} .shape {behavior:url(#default#VML);}

Oct 27, 2015 – The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), no longer uses the terms substance abuse and substance dependence, rather it refers to substance use disorders, which are defined as mild, moderate, or severe to indicate the level of severity, which is determined by the number of …

What is Opioid Use Disorder in the New DSM-5 – Verywell

www.verywell.com › … › Information on Heroin Addiction

  1. Cached

Feb 17, 2016 – The diagnostic criteria for Opioid Use Disorder, a substance use disorder in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).